Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Infectious diseases in patients with solid tumors]

W Lotze1, H Spitzbart

  • 1Meininger Kliniken gGmbH, Meiningen.

Zentralblatt Fur Gynakologie
|January 1, 1995
PubMed
Summary

Effective infection control in cancer patients is crucial. Prophylaxis and prompt treatment of opportunistic infections improve outcomes and quality of life for individuals with malignant diseases.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[The significance of interleukins and of Candida-IgE in chronic recurrent vulvovaginal candidosis].

Mycoses·2005
Same author

[Recurrent infections of female genitalia. Weak immunity or wrong therapy?].

MMW Fortschritte der Medizin·2003
Same author

Immunotherapy of gynaecological high-risk human papilloma virus infection with human leukocyte ultrafiltrate.

Infectious diseases in obstetrics and gynecology·2000
Same author

[VII. International Congress on Infections in Gynecology and Obstetrics 4-7 March 1992 in Munich].

Zentralblatt fur Gynakologie·1992
Same author

[Current aspects of diagnosis, therapy and follow-up care of ovarian carcinoma].

Zeitschrift fur arztliche Fortbildung·1991
Same author

[Sexual rehabilitation of patients with cervix cancer].

Geburtshilfe und Frauenheilkunde·1990

Area of Science:

  • Oncology
  • Immunology
  • Infectious Diseases

Context:

  • Malignant diseases significantly impact patient prognosis and quality of life through immunodeficiency.
  • High infection rates (up to 40%) in cancer patients stem from the primary disease, tumor therapies, and other factors.
  • Myelosuppressive effects of chemotherapy, particularly cytostatics, compromise the immune defense mechanism.

Purpose:

  • To highlight the critical role of infection prevention and management in oncology.
  • To underscore the necessity of a rigorous antimicrobial regimen and specific infection prophylaxis.
  • To emphasize the need for prompt, effective, and potentially combination therapy for opportunistic infections.

Summary:

  • Severe infections are linked to nearly two-thirds of cancer-related deaths.
  • Initial treatment involves broad-spectrum antibiotics, followed by antifungals if necessary.
  • Key success indicators include rapid normalization of body temperature and improved patient well-being.

Impact:

  • Implementing comprehensive primary and secondary prevention strategies can stabilize the immune system of cancer patients.
  • Minimizing infection risk is essential for improving treatment outcomes and patient survival in oncology.
  • Proactive antimicrobial management is vital for reducing mortality associated with infections in cancer care.

Related Experiment Videos